Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. ICRP Glossary‏‎ (267 revisions)
  2. Application of ionising radiation in healthcare‏‎ (98 revisions)
  3. Information for healthcare providers‏‎ (80 revisions)
  4. Information for patients, family members, carers and the public‏‎ (62 revisions)
  5. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  6. System Of Radiation Protection Overview‏‎ (43 revisions)
  7. General Information on Radon‏‎ (31 revisions)
  8. Main Page‏‎ (29 revisions)
  9. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  10. Information for healthcare providers (old)‏‎ (24 revisions)
  11. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  12. Radon For Governments and Employers‏‎ (23 revisions)
  13. Effective dose‏‎ (23 revisions)
  14. Radon For Homeowners and Residents‏‎ (22 revisions)
  15. The System of Radiological Protection‏‎ (21 revisions)
  16. Guide to Radon‏‎ (19 revisions)
  17. Tissue weighting factor‏‎ (17 revisions)
  18. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  19. System of radiation protection module 2‏‎ (14 revisions)
  20. ICRP publications‏‎ (14 revisions)
  21. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  22. Equivalent dose‏‎ (11 revisions)
  23. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  24. Air-kerma rate constant‏‎ (9 revisions)
  25. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  26. Absorbed dose‏‎ (9 revisions)
  27. Objectives of Radiological Protection‏‎ (9 revisions)
  28. Beneficence‏‎ (8 revisions)
  29. Prudence‏‎ (8 revisions)
  30. Effects of Exposure‏‎ (8 revisions)
  31. Organ/tissue absorbed dose‏‎ (8 revisions)
  32. Collective effective dose‏‎ (7 revisions)
  33. ICRPædia Guides‏‎ (6 revisions)
  34. Exposure Categories and Situations‏‎ (6 revisions)
  35. Justice‏‎ (6 revisions)
  36. Alimentary tract‏‎ (6 revisions)
  37. Linear energy transfer‏‎ (6 revisions)
  38. Accelerated fractionation‏‎ (6 revisions)
  39. Investigation level‏‎ (6 revisions)
  40. Dose coefficient‏‎ (5 revisions)
  41. Justification‏‎ (5 revisions)
  42. Kerma‏‎ (5 revisions)
  43. Protection quantities‏‎ (5 revisions)
  44. Types of materials‏‎ (5 revisions)
  45. Radiation weighting factor‏‎ (5 revisions)
  46. Absorbed fraction‏‎ (5 revisions)
  47. Sources of Radiation Exposure‏‎ (5 revisions)
  48. Quality factor‏‎ (5 revisions)
  49. Principle of optimisation‏‎ (5 revisions)
  50. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  51. Air-kerma, entrance surface‏‎ (5 revisions)
  52. Air-kerma, product‏‎ (4 revisions)
  53. Mass median diameter‏‎ (4 revisions)
  54. Fractionation sensitivity‏‎ (4 revisions)
  55. Math‏‎ (4 revisions)
  56. Programmed cell death‏‎ (4 revisions)
  57. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  58. High linear energy transfer radiation‏‎ (4 revisions)
  59. Reference Animal and Plant‏‎ (4 revisions)
  60. Kp index‏‎ (4 revisions)
  61. Bioassay‏‎ (4 revisions)
  62. Calculating Radon Doses‏‎ (4 revisions)
  63. Computed tomography dose index‏‎ (4 revisions)
  64. Protective action‏‎ (4 revisions)
  65. Direct bioassay‏‎ (4 revisions - redirect page)
  66. Alpha decay‏‎ (4 revisions)
  67. Effective charge number‏‎ (4 revisions)
  68. Source-related assessment‏‎ (4 revisions)
  69. Reference bioassay function‏‎ (4 revisions)
  70. Risk‏‎ (4 revisions)
  71. Senescence‏‎ (4 revisions)
  72. Effective half-life‏‎ (4 revisions)
  73. Averted dose‏‎ (4 revisions)
  74. Optimisation‏‎ (4 revisions)
  75. Sievert‏‎ (4 revisions)
  76. S coefficient (radiation weighted)‏‎ (4 revisions)
  77. Forbiddenness‏‎ (4 revisions)
  78. Aerodynamic diameter‏‎ (4 revisions)
  79. ICRP‏‎ (4 revisions)
  80. Non-maleficence‏‎ (4 revisions)
  81. Diagnostic reference level‏‎ (4 revisions)
  82. Fractionation‏‎ (3 revisions)
  83. Organ dose equivalent‏‎ (3 revisions)
  84. Active (red) bone marrow‏‎ (3 revisions)
  85. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  86. Recovery‏‎ (3 revisions)
  87. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  88. Spread-out Bragg peak‏‎ (3 revisions)
  89. Coster-Kronig transition‏‎ (3 revisions)
  90. Emergency preparedness‏‎ (3 revisions)
  91. Gray‏‎ (3 revisions)
  92. Wisdom‏‎ (3 revisions)
  93. Emergency procedures‏‎ (3 revisions)
  94. Absolute risk‏‎ (3 revisions)
  95. Auger transition‏‎ (3 revisions)
  96. Target region‏‎ (3 revisions)
  97. Bystander effect‏‎ (3 revisions)
  98. Employer‏‎ (3 revisions)
  99. Activity median thermodynamic diameter‏‎ (3 revisions)
  100. Complex tissues‏‎ (3 revisions)
  101. Derived air concentration‏‎ (3 revisions)
  102. Dignity‏‎ (3 revisions)
  103. Growth fraction‏‎ (3 revisions)
  104. Potential exposure‏‎ (3 revisions)
  105. Excretion rate (instantaneous)‏‎ (3 revisions)
  106. Rigidity threshold‏‎ (3 revisions)
  107. Extrathoracic airways‏‎ (3 revisions)
  108. Galactic cosmic radiation‏‎ (3 revisions)
  109. Growth hormone (somatotropin)‏‎ (3 revisions)
  110. Low Earth orbit‏‎ (3 revisions)
  111. ICRP Publication 103‏‎ (3 revisions)
  112. X ray‏‎ (3 revisions)
  113. Fairness‏‎ (3 revisions)
  114. Absorption‏‎ (3 revisions)
  115. Gamma ray‏‎ (3 revisions)
  116. Unsealed source‏‎ (3 revisions)
  117. Xerostomia‏‎ (3 revisions)
  118. DNA damage signalling‏‎ (3 revisions)
  119. Dose equivalent‏‎ (3 revisions)
  120. Field-size effect (Volume effect)‏‎ (3 revisions)
  121. Gastrointestinal syndrome‏‎ (3 revisions)
  122. Interphase death‏‎ (3 revisions)
  123. Test‏‎ (3 revisions)
  124. Biomedical research volunteer‏‎ (3 revisions)
  125. Cardiomyopathy‏‎ (3 revisions)
  126. Public exposure‏‎ (3 revisions)
  127. Dose limit‏‎ (3 revisions)
  128. Flexible tissues‏‎ (3 revisions)
  129. Guide to the System of Radiological Protection‏‎ (3 revisions)
  130. Autonomy‏‎ (3 revisions)
  131. Uptake‏‎ (3 revisions)
  132. Dose limits‏‎ (3 revisions)
  133. Fluence‏‎ (3 revisions)
  134. Utilitarian ethics‏‎ (3 revisions)
  135. Operational quantity‏‎ (3 revisions)
  136. Constancy test‏‎ (3 revisions)
  137. Dose‏‎ (3 revisions)
  138. Fluoroscopically guided interventions‏‎ (3 revisions)
  139. Annual dose‏‎ (3 revisions)
  140. Value judgement‏‎ (3 revisions)
  141. DS02‏‎ (3 revisions)
  142. Dose of record (E)‏‎ (3 revisions)
  143. Accountability‏‎ (3 revisions)
  144. Half-life, physical‏‎ (3 revisions)
  145. Cell death‏‎ (3 revisions)
  146. Valvular heart disease‏‎ (3 revisions)
  147. Contamination‏‎ (3 revisions)
  148. Personal dose equivalent‏‎ (3 revisions)
  149. Principle of justification‏‎ (3 revisions)
  150. Radiofrequency ablation‏‎ (3 revisions)
  151. Exponential survival curve‏‎ (3 revisions)
  152. Iso-effect plots‏‎ (3 revisions)
  153. Annual limit on intake‏‎ (3 revisions)
  154. Lifetime risk estimates‏‎ (3 revisions)
  155. Virtue ethics‏‎ (3 revisions)
  156. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  157. Dose per content function‏‎ (3 revisions)
  158. Equity‏‎ (3 revisions)
  159. Graded approach‏‎ (3 revisions)
  160. Isomers‏‎ (3 revisions)
  161. Voxel phantom‏‎ (3 revisions)
  162. Dose per unit intake coefficient‏‎ (2 revisions)
  163. Emergency‏‎ (2 revisions)
  164. Reproductive integrity‏‎ (2 revisions)
  165. Exposure, external or internal‏‎ (2 revisions)
  166. Safety case‏‎ (2 revisions)
  167. Slow repair‏‎ (2 revisions)
  168. Graft vs host disease‏‎ (2 revisions)
  169. Air-kerma, incident‏‎ (2 revisions)
  170. Isotropic geometry‏‎ (2 revisions)
  171. Heliosphere‏‎ (2 revisions)
  172. Lineal energy‏‎ (2 revisions)
  173. Thyroid blocking‏‎ (2 revisions)
  174. Transparency‏‎ (2 revisions)
  175. Class SR-0 gases‏‎ (2 revisions)
  176. Waste disposal‏‎ (2 revisions)
  177. Non-targeted effects‏‎ (2 revisions)
  178. Decontamination‏‎ (2 revisions)
  179. Procedural values‏‎ (2 revisions)
  180. Diastasis‏‎ (2 revisions)
  181. Dose rate‏‎ (2 revisions)
  182. Reasonableness‏‎ (2 revisions)
  183. Emergency exposure situation‏‎ (2 revisions)
  184. Erythropoietin‏‎ (2 revisions)
  185. Residual dose‏‎ (2 revisions)
  186. Exposure (in the context of inhalation)‏‎ (2 revisions)
  187. Safety culture‏‎ (2 revisions)
  188. Fractionation and dose delivery patterns‏‎ (2 revisions)
  189. Solar cosmic radiation‏‎ (2 revisions)
  190. Inhalability‏‎ (2 revisions)
  191. Spontaneous fission‏‎ (2 revisions)
  192. Itinerant (radiation) worker‏‎ (2 revisions)
  193. Linear-non-threshold model‏‎ (2 revisions)
  194. Broad beam therapy irradiation technique‏‎ (2 revisions)
  195. Trapped particles‏‎ (2 revisions)
  196. Class SR-1 gases‏‎ (2 revisions)
  197. Committed effective dose‏‎ (2 revisions)
  198. Orphan source‏‎ (2 revisions)
  199. Cost-benefit analysis‏‎ (2 revisions)
  200. Planned exposure situation‏‎ (2 revisions)
  201. Decontamination factor‏‎ (2 revisions)
  202. Progenitor cell‏‎ (2 revisions)
  203. Radiation belt‏‎ (2 revisions - redirect page)
  204. Radiological protection principles‏‎ (2 revisions)
  205. Dose rate effectiveness factor‏‎ (2 revisions)
  206. Emergency plan‏‎ (2 revisions)
  207. Ethics‏‎ (2 revisions)
  208. Respiratory protection‏‎ (2 revisions)
  209. ALARA‏‎ (2 revisions)
  210. Scintigraphy‏‎ (2 revisions)
  211. Solar cycle‏‎ (2 revisions)
  212. Inner bremsstrahlung‏‎ (2 revisions)
  213. Hierarchical tissues‏‎ (2 revisions)
  214. Area monitoring‏‎ (2 revisions)
  215. Systemic model‏‎ (2 revisions)
  216. Linear-quadratic dose response model‏‎ (2 revisions)
  217. Benthic‏‎ (2 revisions)
  218. Time factor‏‎ (2 revisions)
  219. Bronchial region‏‎ (2 revisions)
  220. Myocardial perfusion‏‎ (2 revisions)
  221. Class SR-2 gases‏‎ (2 revisions)
  222. What is Radon?‏‎ (2 revisions)
  223. Committed equivalent dose‏‎ (2 revisions)
  224. Platelet-derived growth factor‏‎ (2 revisions)
  225. Dichotomous‏‎ (2 revisions)
  226. Radiation modifier‏‎ (2 revisions)
  227. Radionuclides of natural origin‏‎ (2 revisions)
  228. Recovery (cellular or tissue)‏‎ (2 revisions)
  229. Retrievability‏‎ (2 revisions)
  230. Immune system‏‎ (2 revisions)
  231. Activity‏‎ (2 revisions)
  232. Institutional control‏‎ (2 revisions)
  233. Stakeholder‏‎ (2 revisions)
  234. High level waste‏‎ (2 revisions)
  235. Tachycardia‏‎ (2 revisions)
  236. Tissue equivalent material‏‎ (2 revisions)
  237. Myocardial stress test‏‎ (2 revisions)
  238. Clearance‏‎ (2 revisions)
  239. Oversight‏‎ (2 revisions)
  240. Deontological Ethics‏‎ (2 revisions)
  241. Projected dose‏‎ (2 revisions)
  242. Differentiation‏‎ (2 revisions)
  243. Dose constraint‏‎ (2 revisions)
  244. Radioresponsiveness‏‎ (2 revisions)
  245. Early normal tissue responses‏‎ (2 revisions)
  246. Recovery responder‏‎ (2 revisions)
  247. Reversibility‏‎ (2 revisions)
  248. In vivo radiobioassay‏‎ (2 revisions)
  249. Solar particle event‏‎ (2 revisions)
  250. Beta-minus decay‏‎ (2 revisions)
  251. Clearance level‏‎ (2 revisions)
  252. Worker‏‎ (2 revisions)
  253. Nuclear track detectors‏‎ (2 revisions)
  254. Radiation safety officer‏‎ (2 revisions)
  255. Dose conversion coefficient‏‎ (2 revisions)
  256. Radiosensitiser‏‎ (2 revisions)
  257. Edema‏‎ (2 revisions)
  258. Rehabilitation of living conditions‏‎ (2 revisions)
  259. Excess relative risk‏‎ (2 revisions)
  260. Right to know‏‎ (2 revisions)
  261. Exposure situation‏‎ (2 revisions)
  262. Incidence‏‎ (2 revisions)
  263. Solar wind‏‎ (2 revisions)
  264. Growth factor‏‎ (2 revisions)
  265. Alimentary tract transfer factor‏‎ (2 revisions)
  266. Target tissue‏‎ (2 revisions)
  267. Beta-plus decay‏‎ (2 revisions)
  268. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  269. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  270. Working level‏‎ (2 revisions)
  271. OLINDA/EXM‏‎ (2 revisions)
  272. Particle radiance‏‎ (2 revisions)
  273. Cumulative dose‏‎ (2 revisions)
  274. Protection strategy‏‎ (2 revisions)
  275. Radiation source‏‎ (2 revisions)
  276. Radiosensitivity, cellular‏‎ (2 revisions)
  277. Effect Dose 50‏‎ (2 revisions)
  278. Endogeneous excretion‏‎ (2 revisions)
  279. Rigidity‏‎ (2 revisions)
  280. Exposure to Radon at Home‏‎ (2 revisions)
  281. Security‏‎ (2 revisions)
  282. Incident‏‎ (2 revisions)
  283. GATA binding protein 2‏‎ (2 revisions)
  284. Intermediate level waste‏‎ (2 revisions)
  285. Stenosis‏‎ (2 revisions)
  286. Hormones‏‎ (2 revisions)
  287. Authorization‏‎ (2 revisions)
  288. Local DRL‏‎ (2 revisions)
  289. Tolerability‏‎ (2 revisions)
  290. Medical exposure‏‎ (2 revisions)
  291. Naturally occurring radioactive material‏‎ (2 revisions)
  292. Clonogenic cells‏‎ (2 revisions)
  293. Working level month‏‎ (2 revisions)
  294. Curie‏‎ (2 revisions)
  295. Inclusiveness‏‎ (2 revisions)
  296. Acute radiation syndrome‏‎ (2 revisions)
  297. Source-related‏‎ (2 revisions)
  298. Internal conversion electron‏‎ (2 revisions)
  299. LD 50/30‏‎ (2 revisions)
  300. Hounsfield unit‏‎ (2 revisions)
  301. Authorized limit‏‎ (2 revisions)
  302. Telangiectasia‏‎ (2 revisions)
  303. Member of the public‏‎ (2 revisions)
  304. Cardiac arrhythmias‏‎ (2 revisions)
  305. Unattached fraction‏‎ (2 revisions)
  306. Necrosis‏‎ (2 revisions)
  307. Clonogenic survival‏‎ (2 revisions)
  308. Patient entrance reference point‏‎ (2 revisions)
  309. Cytokines‏‎ (2 revisions)
  310. Potential recoverability correction factor‏‎ (2 revisions)
  311. Protective action guide‏‎ (2 revisions)
  312. Radiation worker‏‎ (2 revisions)
  313. Dose criteria‏‎ (2 revisions)
  314. Radon: Units of Measure‏‎ (2 revisions)
  315. Reference air kerma‏‎ (2 revisions)
  316. Environmental exposure‏‎ (2 revisions)
  317. Exempt waste‏‎ (2 revisions)
  318. Self-help protection‏‎ (2 revisions)
  319. Individual-related‏‎ (2 revisions)
  320. Adaptive response‏‎ (2 revisions)
  321. Alveolar-interstitial region‏‎ (2 revisions)
  322. Storage‏‎ (2 revisions)
  323. Autoimmune disease‏‎ (2 revisions)
  324. Track structure‏‎ (2 revisions)
  325. Mendelian diseases‏‎ (2 revisions)
  326. ICRP Publication 118‏‎ (2 revisions)
  327. Cardiac valve diseases‏‎ (2 revisions)
  328. Neurological syndrome‏‎ (2 revisions)
  329. Occupational exposure‏‎ (2 revisions)
  330. Peak skin dose‏‎ (2 revisions)
  331. Disposal‏‎ (2 revisions)
  332. Radioactive dispersion device‏‎ (2 revisions)
  333. Environmental radiation protection‏‎ (2 revisions)
  334. Exemption level‏‎ (2 revisions)
  335. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  336. Individual decontamination‏‎ (2 revisions)
  337. Subcutaneous tissue‏‎ (2 revisions)
  338. Low dose rate‏‎ (2 revisions)
  339. Transfer compartment‏‎ (2 revisions)
  340. Mitigation‏‎ (2 revisions)
  341. Upper reference levels‏‎ (2 revisions)
  342. Neurovascular syndrome‏‎ (2 revisions)
  343. Co-expertise‏‎ (2 revisions)
  344. Connective tissue‏‎ (2 revisions)
  345. Pelagic‏‎ (2 revisions)
  346. DRL process‏‎ (2 revisions)
  347. Practical radiological protection culture‏‎ (2 revisions)
  348. Radioactive source‏‎ (2 revisions)
  349. Effective dose equivalent‏‎ (2 revisions)
  350. Reference biokinetic model‏‎ (2 revisions)
  351. Relocation‏‎ (2 revisions)
  352. Existing exposure situation‏‎ (2 revisions)
  353. Risk coefficient‏‎ (2 revisions)
  354. Individual monitoring‏‎ (2 revisions)
  355. Gastroschisis‏‎ (2 revisions)
  356. Source term‏‎ (2 revisions)
  357. Angiogenesis‏‎ (2 revisions)
  358. Latent time/period or latency interval‏‎ (2 revisions)
  359. Hyperbaric oxygen‏‎ (2 revisions)
  360. Low level waste‏‎ (2 revisions)
  361. Bioturbation‏‎ (2 revisions)
  362. Cardioverter-defibrillator‏‎ (2 revisions)
  363. Consequential late effects‏‎ (2 revisions)
  364. Qualified expert‏‎ (2 revisions)
  365. Radioactive substance‏‎ (2 revisions)
  366. Radon Recommendations for Authorities‏‎ (2 revisions)
  367. Reference individual‏‎ (2 revisions)
  368. Epithelium‏‎ (2 revisions)
  369. Remedial action‏‎ (2 revisions)
  370. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  371. Acceptance test‏‎ (2 revisions)
  372. Gastrulation‏‎ (2 revisions)
  373. Intervention Level‏‎ (2 revisions)
  374. Habitual mouth breather‏‎ (2 revisions)
  375. Annihilation photons‏‎ (2 revisions)
  376. Substantial radiation dose level‏‎ (2 revisions)
  377. Hyperfractionation‏‎ (2 revisions)
  378. Bone marrow‏‎ (2 revisions)
  379. Transfer rate‏‎ (2 revisions)
  380. Multi-detector computed tomography‏‎ (2 revisions)
  381. Cohort study‏‎ (2 revisions)
  382. Percutaneous coronary intervention‏‎ (2 revisions)
  383. DRL value‏‎ (2 revisions)
  384. Prevailing circumstances‏‎ (2 revisions)
  385. Radon Recommendations for Workplaces‏‎ (2 revisions)
  386. Reference level‏‎ (2 revisions)
  387. Equieffective dose‏‎ (2 revisions)
  388. Remediation‏‎ (2 revisions)
  389. Expanded and aligned radiation field‏‎ (2 revisions)
  390. Risk of Exposure to Radon‏‎ (2 revisions)
  391. Adventitious‏‎ (2 revisions)
  392. South Atlantic anomaly‏‎ (2 revisions)
  393. Interventional procedure‏‎ (2 revisions)
  394. Habitual nose breather‏‎ (2 revisions)
  395. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  396. Background dose (rate)‏‎ (2 revisions)
  397. Lymphatic system‏‎ (2 revisions)
  398. Transforming growth factor‏‎ (2 revisions)
  399. Containment‏‎ (2 revisions)
  400. Pericarditis‏‎ (2 revisions)
  401. Principle of application of dose limits‏‎ (2 revisions)
  402. Dose-length product‏‎ (2 revisions)
  403. Radioactivity‏‎ (2 revisions)
  404. Electron-capture decay‏‎ (2 revisions)
  405. Repopulation‏‎ (2 revisions)
  406. Routine monitoring‏‎ (2 revisions)
  407. ICRPædia Guide to Radon‏‎ (2 revisions)
  408. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  409. Special (non-routine) monitoring‏‎ (2 revisions)
  410. Lifetime risk‏‎ (2 revisions)
  411. Hypoplasia‏‎ (2 revisions)
  412. Backscatter detection system‏‎ (2 revisions)
  413. Macrophage colony stimulating factor‏‎ (2 revisions)
  414. Bradycardia‏‎ (2 revisions)
  415. Multiplicative risk projection model‏‎ (2 revisions)
  416. Detriment‏‎ (2 revisions)
  417. Dose-rate effect‏‎ (2 revisions)
  418. Dose of record Hp (10)‏‎ (2 revisions)
  419. Electrophysiology‏‎ (2 revisions)
  420. Representative organism (non-human biota)‏‎ (2 revisions)
  421. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  422. Accreditation‏‎ (2 revisions)
  423. Genomic integrity‏‎ (2 revisions)
  424. Hazard‏‎ (2 revisions)
  425. Threshold dose for tissue reactions‏‎ (2 revisions)
  426. Magnetosphere‏‎ (2 revisions)
  427. Bragg peak‏‎ (2 revisions)
  428. Coronary heart disease‏‎ (2 revisions)
  429. Decay constant‏‎ (2 revisions)
  430. Radiographer‏‎ (2 revisions)
  431. Representative person‏‎ (2 revisions)
  432. Safety‏‎ (2 revisions)
  433. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  434. Action Level‏‎ (2 revisions)
  435. Specific effective energy‏‎ (2 revisions)
  436. Health Surveillance‏‎ (2 revisions)
  437. Limitation of dose‏‎ (2 revisions)
  438. Basal cell‏‎ (2 revisions)
  439. Branching fraction‏‎ (2 revisions)
  440. Transmission detection system‏‎ (2 revisions)
  441. Multistage tumorigenesis‏‎ (2 revisions)
  442. Chronic exposure‏‎ (2 revisions)
  443. Non-sphericity parameter‏‎ (2 revisions)
  444. Colony‏‎ (2 revisions)
  445. Cosmic Radiation in Aviation‏‎ (2 revisions)
  446. Pharynx‏‎ (2 revisions)
  447. Decommissioning‏‎ (2 revisions)
  448. Dose-threshold‏‎ (2 revisions)
  449. ICRP Publication 5‏‎ (1 revision)
  450. Dose-threshold hypothesis‏‎ (1 revision)
  451. Radiological attack‏‎ (1 revision)
  452. ICRP Publication 64‏‎ (1 revision)
  453. Reactive oxygen species‏‎ (1 revision)
  454. ICRP Publication 79‏‎ (1 revision)
  455. Reference worker‏‎ (1 revision)
  456. ICRP Publication 92‏‎ (1 revision)
  457. 1956 Recommendations‏‎ (1 revision)
  458. Activation‏‎ (1 revision)
  459. Informed consent‏‎ (1 revision)
  460. Spongiosa‏‎ (1 revision)
  461. ICRP Publication 1‏‎ (1 revision)
  462. Baseline disease rates‏‎ (1 revision)
  463. Marrow cellularity‏‎ (1 revision)
  464. ICRP Publication 110‏‎ (1 revision)
  465. Breakpoint cluster region/abelson‏‎ (1 revision)
  466. Multitarget equation‏‎ (1 revision)
  467. ICRP Publication 125‏‎ (1 revision)
  468. ICRP Publication 14‏‎ (1 revision)
  469. Commissioning‏‎ (1 revision)
  470. ICRP Publication 154‏‎ (1 revision)
  471. Cosmic radiation‏‎ (1 revision)
  472. Pilomatricoma‏‎ (1 revision)
  473. ICRP Publication 29‏‎ (1 revision)
  474. ICRP Publication 35‏‎ (1 revision)
  475. Radiation-induced secondary malignancy‏‎ (1 revision)
  476. ICRP Publication 50‏‎ (1 revision)
  477. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  478. Radiological controlled area‏‎ (1 revision)
  479. ICRP Publication 65‏‎ (1 revision)
  480. ICRP Publication 8‏‎ (1 revision)
  481. Referrer‏‎ (1 revision)
  482. ICRP Publication 93‏‎ (1 revision)
  483. 1959 Decisions‏‎ (1 revision)
  484. ICRU 4-element tissue‏‎ (1 revision)
  485. Hereditary effect‏‎ (1 revision)
  486. System of radiological protection‏‎ (1 revision)
  487. ICRP Publication 10‏‎ (1 revision)
  488. Time-resolved computed tomography‏‎ (1 revision)
  489. ICRP Publication 111‏‎ (1 revision)
  490. Mutation component‏‎ (1 revision)
  491. ICRP Publication 126‏‎ (1 revision)
  492. Waste management‏‎ (1 revision)
  493. Normal tissue complication probability‏‎ (1 revision)
  494. ICRP Publication 140‏‎ (1 revision)
  495. ICRP Publication 155‏‎ (1 revision)
  496. ICRP Publication 3‏‎ (1 revision)
  497. ICRP Publication 36‏‎ (1 revision)
  498. Dicentric chromosome‏‎ (1 revision)
  499. ICRP Publication 51‏‎ (1 revision)
  500. ICRP Publication 66‏‎ (1 revision)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)